The First Experience of Combined Use of Cefepime/Sulbactam and Aztreonam in ICU Patients with Nosocomial Infections Caused by Carbapenem-Resistant Gram-Negative Microorganisms Producing Class B and D Carbapenemases

The First Experience of Combined Use of Cefepime/Sulbactam and Aztreonam in ICU Patients with Nosocomial Infections Caused by Carbapenem-Resistant Gram-Negative Microorganisms Producing Class B and D Carbapenemases

Background. The difficulties of antibacterial therapy of infections caused by carbapenemase-producing  gram-negative bacteria are associated with limited options for adequate therapy since, in addition to resistance to carbapenems and other beta-lactams, these microorganisms are often characterized by...

Full description

Saved in:
Bibliographic Details
Main Authors: M. P. Suvorova, I. N. Sychev, O. V. Ignatenko, E. N. Burmistrova, S. S. Mirzakhamidova, L. V. Fedina, R. M. Vakolyuk, S. V. Yakovlev
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2023-02-01
Series:Антибиотики и Химиотерапия
Subjects:
cefepime/sulbactam
aztreonam
carbapenemase
ndm
oxa-48
klebsiella pneumoniae
nosocomial infections
xdr pathogens: pdr pathogens
prospective clinical study
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/986
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.antibiotics-chemotherapy.ru/jour/article/view/986

Similar Items